What a fat-headed load of steaming codswallop.
By all means, join the dots on former directors, their relationships and networks that may lead to the first clinical evaluation of ALA's technology.
Casting aspersions on former directors with an infintessimally small holding, is fallacious in the extreme.
Ann: Investor Presentation Imugene Arovella Therapies, page-6
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.0¢ |
Change
0.005(3.70%) |
Mkt cap ! $147.2M | |||
| Open | High | Low | Value | Volume |
| 13.5¢ | 14.5¢ | 13.5¢ | $174.0K | 1.245M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 61995 | 14.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.5¢ | 183155 | 1 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| ALA (ASX) Chart |